Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
4,803 total articles
CZMWF looks like it's forming a low-volatility base around the low $30s with bullish momentum indicators and abnormally high short interest. This is a tactical long trade on the view that price action, a thin float, and positive technicals can produce a 15-20% move within a mid-term window. The trade is higher-risk because the stock trades OTC with…
Imperial Oil (IMO) looks set to compound shareholder returns as upstream volumes rise and free cash flow remains robust. With production guidance for 2026, a healthy dividend, and a conservative debt profile, the risk-reward now favors a long exposure. Technicals and elevated short interest argue for disciplined sizing and a defined stop.
Workday is trading well below last years highs but still generates strong free cash flow and carries a defensible position in HR/Finance cloud software. This trade targets a re-rating to a mid-teens EV/FCF multiple as enterprise budgets stabilize and AI-driven integrations accelerate adoption. Entry $130.00, target $160.00, stop $115.00 - long ter…
Molina Healthcare's stock has been knocked down by a volatile earnings quarter and Medicaid margin pressure, but the underlying business, predictable revenue streams, and an attractive valuation make it a compelling long-term trade. This note lays out a clear entry, stop and target, the fundamental case, catalysts to watch, and the risks that could…
Gold Fields (GFI) looks positioned to re-rate as Salares Norte transitions from optionality to real production potential. At $46.50 the stock offers a mix of yield (2.46%), a sub-13x P/E, and bullish technical momentum. This trade idea outlines an entry at $46.50, a stop at $43.00 and a target at $58.00 over a mid-term horizon (45 trading days).
O'Reilly traded to a 52-week low after a narrow Q4 miss and margin pressure, but fundamentals and technicals argue this pullback is a buying window. We lay out an explicit entry at $93.82, a stop at $86.77 and a $110 target over the next 180 trading days.
CZMWF sits at the crossroads of solid technical momentum and poor market optics: trading on OTC Link with low liquidity, extreme short interest, and noisy daily volumes. Technical indicators show bullish momentum around the $32 area, and intermittent short-volume spikes create the potential for a squeeze. This is a high-risk, actionable long setup …
POET (ticker: POET) is a tiny photonics platform with a $1.57B market cap trading on headlines about PFIC remediation, strategic partnerships, and sample timelines for AI optical modules. The stock is volatile and crowded — we outline a position trade (120 trading days) with clear entry, stop and ambitious upside while flagging the structural execu…
IREN is a differentiated infrastructure play: vertically integrated, renewable-rich campus sites and a $9.7B hyperscaler engagement put the company at the center of AI compute bottlenecks. The stock has rallied but still trades on stretched multiples and a capital-hungry expansion plan that market reports peg near $6B of new funding. This trade ide…
Amneal's move into metered-dose inhalation products, a progressing biosimilar program, and improving free cash flow create a favorable risk/reward from current levels. We recommend a tactical long with a mid-term horizon to capture commercial ramp and clinical readouts while respecting operational and regulatory risks.
Columbia Seligman Premium Technology Growth Fund (STK) is a tech-focused covered-call closed-end fund that currently yields ~4.0%, trades at a low earnings multiple, and shows strong technical momentum. For investors who want tech exposure with income and a measure of downside cushioning, STK offers a more balanced path than a straight growth bet o…
Oracle has moved from an AI underdog to a central infrastructure supplier as OpenAI and Anthropic chase scale. With partner-funded data-center expansion, accelerating RPO and a string of recent commercial wins, Oracle is positioned to capture the revenue and margin upside from the enterprise AI arms race. This trade targets continued re-rating over…
Applied Optoelectronics (AAOI) has moved from speculative turnaround to commercial momentum: multiple hyperscale volume orders for 800G and 1.6T transceivers, a major new Texas manufacturing campus and plans to scale to 500k combined units/month underpin a long-term trade. The valuation is rich and fundamentals show losses and negative free cash fl…
Cybin (CYBN) is a clinical-stage neuropsychiatric company trading at a modest ~$298M market cap. Recent regulatory and policy signals, expanding analyst coverage, and a live Phase II program create an asymmetric risk/reward for a tactical long. We upgrade to a buy and lay out a clear entry at $8.00, a stop at $5.50 and targets at $12.00 (mid) and $…
Travere (TVTX) looks attractively positioned if FILSPARI (sparsentan) captures FSGS market share or becomes an acquisition target. The stock trades at a market cap of roughly $3.58B despite negative earnings, modest free cash flow, and material leverage. This trade idea lays out a clear entry, stop and target with a long-term horizon while flagging…
Advanced Micro Devices (AMD) has rallied into fresh 52-week highs with strong momentum and improving data-center positioning. I see a clear, actionable long setup into $300 over the next 45 trading days, with an entry at $285, a stop at $265 and a $300 target. The thesis leans on accelerating AI demand, improving free cash flow and conservative bal…
Credo's $750M acquisition of DustPhotonics and management guidance for >$500M optical revenue in fiscal 2027 materially changes the company's growth profile. Pairing best-in-class active electrical cables with in-house silicon photonics gives Credo a pathway to multiple new rack-to-rack and rack-to-optic upgrade cycles at hyperscalers. Valuation re…
Southern Copper (SCCO) remains in a constructive uptrend supported by solid cash generation, strong returns and a tight copper market. The setup favors adding exposure on modest weakness with a clear stop and a 180-trading-day target toward prior highs.
Red Cat (RCAT) is carving out a credible niche in multi-domain intelligence, surveillance and reconnaissance (ISR) with recent M&A and partner wins, an early order book for its Black Widow product, and improving commercial traction. The stock is richly valued versus trailing revenue but offers a clear upside path if execution on autonomy and intern…
Coherent has leapt from deep-cyclical lows into a leadership position in photonics and lasers for data center and semiconductor customers. The company carries a stretched valuation (P/E ~340, P/S ~10.4) and negative free cash flow, yet strong partner endorsements, S&P inclusion and bullish technicals open a tactical buying opportunity for disciplin…
Rocket Lab (RKLB) is a tactical buy ahead of the anticipated SpaceX IPO that should lift demand for launch services and sentiment across the sector. The company combines position in launches, a growing $1.9B backlog and Neutron upside with a stretched valuation and execution risk. This trade recommends a mid-term long with strict risk controls and …
Surf Air Mobility (SRFM) trades like a micro-cap with headline risk, but a meaningful commercial launch of SurfOS and a $100M strategic relationship with Palantir create a near-term path to revenue expansion. Market cap sits below $100M while EV is ~$140M and price-to-sales is 0.87x; for patient, risk-aware traders this is a directional long with d…
AEVEX (AVEX) is a newly public defense-tech firm building a full drone and autonomy stack for ISR and tactical missions. The IPO and recent rally put the stock into growth multiple territory, but strong institutional demand, a $3.22B market cap and visible contract leverage create an actionable mid-term long trade with defined risk controls.
We upgrade Xero to a buy for a mid-term swing: an AI partnership plus positive industry survey results create a clear catalyst path for subscription growth and monetization. Entry at $12.50, stop at $10.50, target $16.00 over roughly 45 trading days if execution and uptake track expectations.
Brookfield Corporation pairs hard assets with an emerging insurance and asset-management engine. At a $103.8B market cap and trading near $46.41, the stock offers asymmetric upside if management converts insurance float and AUM into high-margins and carried interest. This trade targets $65 with a $41 stop, sized for a long-term hold (180 trading da…
